References
- Ducimetière F, Lurkin A, Ranchère-Vince D, Decouvelaere AV, Péoc’h M, Istier L, et al. Incidence of sarcoma histiotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One. 2011; 6:e20294. doi: 10.1371/journal.pone.0020294
- Stojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg. 2002; 235:424–34.
- Smith HG, Panchalingam D, Hannay JA, Smith MJ, Thomas JM, Hayes AJ, Strauss DC. Outcome following resection of retroperitoneal sarcoma. Br J Surg. 2015; 102:1698–709.
- Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998; 228:355–65.
- Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016; 263:1002–9.
- Sriussadaporn S, Sriussadaporn S, Pak-art R, Kritayakirana K, Prichayudh S, Samorn P. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand. J Med Assoc Thai. 2014; 97:598–614.
- Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003; 238:358–70.
- Tan MC, Brennan MF, Kuk D, Agaram NP, Antonescu CR, Qin LX, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg. 2016; 263:593–600.
- Keung EZ, Hornick L, Bertagnolli MM, Baldini EH, Raut CP. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg. 2014; 218:206–17.
- Bonvalot S, Miceli R, Berselli M, Causeret S, Colombo C, Mariani L, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010; 17:1507–14.
- Lee SY, Goh BK, Teo MC, Chew MH, Chow PK, Wong WK, et al. Retroperitoneal liposarcomas: the experience of a tertiary Asian center. World J Surg Oncol. 2011; 9:12. doi: 10.1186/1477-7819-9-12
- Ng DWJ, Tan GHC, Chia CS, Chee SK, Quek R, Farid M, Teo MCC. Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience. Asia Pac J Clin Oncol. 2017; 13:e458–65.
- Luo P, Cai W, Yang L, Wu Z, Chen Y, Zhang R, et al. Retroperitoneal dedifferentiated liposarcoma: analysis of 61 cases from a large institution. J Cancer. 2018; 9:3831–8.
- Snow HA, Hitchen TX, Head J, Herschtal A, Bae S, Chander S, et al. Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from a Australian specialist sarcoma centre. ANZ J Surg. 2018; 88:1151–7.
- Faron M, Cavalcanti A, Honore C. Compartmental resection of a retroperitoneal sarcoma. J Visc Surg. 2019; 156:245–51.
- Coindre JM. Grading of soft tissue sarcoma: review and update. Arch Pathol Lab Med. 2006; 130:1448–53.
- Tseng WW, Seo HJ, Pollock RE, Gronchi A. Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma. J Surg Oncol. 2018; 117:7–11.
- Cody HS 3rd, Turnbull AD, Fortner JG, Hajdu SI. The continuing challenge of retroperitoneal sarcomsas. Cancer. 1981; 47: 2147–52.
- Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg. 1991; 214:2–10.
- Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001; 92: 359–68.
- Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, Laplanche A. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009; 27:31–7.
- Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009; 27:24–30.
- Toulmonde M, Bonvalot S, Ray-Coquard I, Stoeckle E, Riou O, Isambert N, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014; 25:735–42.
- Gronchi A, Miceli R, Shurell E, Eilber FC, Eilber FR, Anaya DA, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013; 31:1649–55.
- Pisters PW. Resection of some-but not all-clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol. 2009; 27:6–8.
- Hull MA, Molina G, Niemierko A, Haynes AB, Jacobson A, Bernstein KA, et al. Improved local control with an aggressive strategy of preoperative (with or without intraoperative) radiation therapy combined with radical surgical resection for retroperitoneal sarcoma. J Surg Oncol. 2017; 115:746–51.
- Molina G, Hull MA, Chen YL, DeLaney TF, De Amorim Bernstein K, Choy E, et al. Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma. J Surg Oncol. 2016; 114:814–20.
- Ecker BL, Peters MG, McMillan MT, Sinnamon AJ, Zhang PJ, Fraker DL, et al. Preoperative radiotherapy in the management of retroperitoneal liposarcoma. Br J Surg. 2016; 103:1839–46.
- Bonvalot S, Gronchi A, Le Péchoux C, Swallow CJ, Strauss D, Meeus P, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020; 21:1366–77.
- Callegaro D, Raut CP, Ajayi T, Strauss D, Bonvalot S, Ng D, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 trial (STRASS) versus off-trial (STREXIT) results. Ann Surg. 2023; 278:127–34.